| 查看: 3068 | 回復(fù): 10 | |||
[求助]
accept with major revision 但意見不多
|
|
Dear Dr Peng, I regret to inform you that your work can be reconsidered for publication only with extensive revisions to your manuscript. The reviewers' advice on the necessary revisions and their comments are appended below. If you are willing to undertake the required amendments, please submit a point by point response listing your changes or justifications to the reviewers' comments when you submit the revised manuscript. With warm regards, Toshio Kitamura Reviewers' comments: A Editorial Board This study, which is carefully performed, is an interesting one. Both reviewers recognized some merit in this paper. Please carefully respond all concerns raised by the reviewers. I have one minor concern Regarding statistic p values, the authors should described them as more accurate number (for example <0.001) instead of 0.00. Reviewer #1: This paper describes the long-term effects of laparoscopic splenectomy (LS) for patients with chronic immune thrombocytopenia (ITP). They also tried to determine the predictive factors for promising hematological outcomes. Along with the advancement in some new drugs including rituximab and thrombopoietin receptor agonists, it is important to re-examine and analyze the long-term effects of LS and the predictive factors for good outcomes. Major issues 1. They retrospectively analyzed the data in 92 patients who underwent LS for chronic ITP. Their remission rate (76.1%) is relatively favorable and indicated that LS is still one of the treatment options for chronic ITP even in an era of new drugs. 2. Using multivariate logistic regression analysis, they showed that only the platelet counts on postoperative months 3 (POM3) was a significant independent prognostic factor for long-time response to LS. This information is also useful to estimate the long-time response for each patient. 3. The authors previously reported about LS for ITP patients (ref 11, Int J Hematol 94:533-538) . In this paper, they analysed 10 ITP patients who underwent LS because of severe thrombocytopenia, from April 2006 to Jan 2011. They have to make clear whether these 10 patients were overlapped with 92 (from Nov 2006 to Aug 2012) patients in the current report or not. 4. They mentioned that one patient has died of severe pulmonary infection after LS on POD 5. I want to know whether this patient was suffered by overwhelming postsplenectomy infection (OPSI). It is also interesting to know whether these patients were given pneumococcal vaccine around LS in their institute. Minor issues 1. In Table 2, they use abbreviated words "RG" and "NG". They should indicate what these abbreviations stand for. Reviewer #2: The authors described the clinical research entitled predictive factors associated with long-term effects of laparoscopic splenectomy for chronic immune thrombocytopenia. In this paper, they clearly demonstrated that platelet count on POM3 was significant independent predictor of long-term favorable outcome. Their conclusions are almost acceptable, however, several questions are raised up as below. 1) Several investigators already reported that young patients showed higher CR responses of splenectomy than those in elderly patients. However, CR rate in this paper was thought to be lower (53.3 %) than expected. 2) It was reported that the good response to IVIG might be available for predictor of successful splenectomy. Did you check this phenomenon in your study? 3) The importance of platelet raise after splenectomy was already well known in hematologists. Some papers reported POM 1 was available as predictable indicator.However, you mentioned the POM3 was significant, not POM 1. You should explain the reason on 求助。有戲沒???徹夜難眠55555555555 |
木蟲 (正式寫手)

至尊木蟲 (知名作家)
超級版主 (文學(xué)泰斗)
No gains, no pains.
![]() |
專家經(jīng)驗(yàn): +21105 |
鐵桿木蟲 (知名作家)
版主 (文學(xué)泰斗)
木蟲 (正式寫手)
研究員
榮譽(yù)版主 (文學(xué)泰斗)
還沒想好
![]() |
專家經(jīng)驗(yàn): +14 |

用戶注銷 (職業(yè)作家)
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 【雙一流院校新能源、環(huán)境材料,材料加工與模擬招收大量調(diào)劑】 +4 | Higraduate 2026-03-22 | 7/350 |
|
|---|---|---|---|---|
|
[考研] 279分求調(diào)劑 一志愿211 +18 | chaojifeixia 2026-03-19 | 20/1000 |
|
|
[考研] 306求0703調(diào)劑一志愿華中師范 +8 | 紙魚ly 2026-03-21 | 9/450 |
|
|
[考研] 一志愿山東大學(xué)藥學(xué)學(xué)碩求調(diào)劑 +3 | 開開心心沒煩惱 2026-03-23 | 4/200 |
|
|
[考研] 298-一志愿中國農(nóng)業(yè)大學(xué)-求調(diào)劑 +11 | 手機(jī)用戶 2026-03-17 | 12/600 |
|
|
[考研] 328求調(diào)劑,英語六級551,有科研經(jīng)歷 +7 | 生物工程調(diào)劑 2026-03-17 | 12/600 |
|
|
[考研] 一志愿南京理工大學(xué)085701資源與環(huán)境302分求調(diào)劑 +5 | 葵梓衛(wèi)隊(duì) 2026-03-18 | 7/350 |
|
|
[考研] 求老師收我 +3 | zzh16938784 2026-03-23 | 3/150 |
|
|
[考研]
|
2117205181 2026-03-21 | 8/400 |
|
|
[考研] 293求調(diào)劑 +3 | 濤濤Wjt 2026-03-22 | 5/250 |
|
|
[考研] 319求調(diào)劑 +4 | 小力氣珂珂 2026-03-20 | 4/200 |
|
|
[考研] 材料學(xué)碩301分求調(diào)劑 +7 | Liyouyumairs 2026-03-21 | 7/350 |
|
|
[考研] 299求調(diào)劑 +5 | shxchem 2026-03-20 | 7/350 |
|
|
[考研] 0805材料320求調(diào)劑 +3 | 深海物語 2026-03-20 | 3/150 |
|
|
[考研] 一志愿中海洋材料工程專碩330分求調(diào)劑 +8 | 小材化本科 2026-03-18 | 8/400 |
|
|
[考研] 0817 化學(xué)工程 299分求調(diào)劑 有科研經(jīng)歷 有二區(qū)文章 +22 | rare12345 2026-03-18 | 22/1100 |
|
|
[考研] 求調(diào)劑 +3 | @taotao 2026-03-20 | 3/150 |
|
|
[考研] 一志愿南理工085701環(huán)境302求調(diào)劑院校 +3 | 葵梓衛(wèi)隊(duì) 2026-03-20 | 3/150 |
|
|
[考研] 材料學(xué)碩318求調(diào)劑 +5 | February_Feb 2026-03-19 | 5/250 |
|
|
[考博] 申博26年 +3 | 八6八68 2026-03-19 | 3/150 |
|